Abbott Laboratories (ABT) Amortization - Intangibles (2012 - 2026)

Abbott Laboratories' Amortization - Intangibles history runs 15 years deep, the most recent figure standing at $422.0 million for Q1 2026.

• In Q1 2026, Amortization - Intangibles changed 0.48% year-over-year to $422.0 million; the TTM figure through Mar 2026 stood at $1.7 billion (down 7.78% YoY), while the FY2025 annual figure was $1.7 billion, down 10.44% from the prior year.
• Amortization - Intangibles came in at $422.0 million for Q1 2026 at Abbott Laboratories, roughly flat from $422.0 million in the prior quarter.
• In the past five years, Amortization - Intangibles ranged from a high of $512.0 million in Q1 2022 to a low of $420.0 million in Q1 2025.
• A 5-year average of $468.3 million and a median of $472.0 million in 2024 frame the typical range for Amortization - Intangibles.
• Across the five-year window, Amortization - Intangibles climbed 0.6% in 2022 and declined 11.02% in 2025, its largest moves.
• Abbott Laboratories' Amortization - Intangibles stood at $496.0 million in 2022, then retreated by 3.02% to $481.0 million in 2023, then decreased by 3.33% to $465.0 million in 2024, then decreased by 9.25% to $422.0 million in 2025, then changed by 0.0% to $422.0 million in 2026.
• According to Business Quant data, Amortization - Intangibles over the past three periods registered $422.0 million, $422.0 million, and $420.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison